Results 1 to 10 of about 1,909 (168)

The Pharmaceutical Industry in 2025: An Analysis of FDA Drug Approvals from the Perspective of Molecules. [PDF]

Molecules
de la Torre BG, Albericio F.
europepmc   +1 more source

Graphene-Based Nanosystem for Targeted Delivery of Anti-Sense miRNA-21 on Hepatocellular Carcinoma Cells. [PDF]

Int J Mol Sci
Trischitta P, Kucharzewska P, Nasiłowska B, Skrzeczanowski W, Pennisi R, Sciortino MT, Kutwin M.   +6 more
europepmc   +1 more source

Modulating G-quadruplexes for therapeutic intervention: Structural diversity, stability, and emerging nucleic-acid-based strategies. [PDF]

Mol Ther Nucleic Acids
Sokulska M, Nalewaj M, Czapik T, Rachwalak M, Szabat M.   +4 more
europepmc   +1 more source

Cell-penetrating antibody enhances nuclear delivery of triplex-forming oligonucleotides targeting HER2-positive cancers. [PDF]

Mol Ther Nucleic Acids
Minnah A, García Tubéns NM, Krysztofiak A, Liu Y, Glazer PM, Rogers FA.   +5 more
europepmc   +1 more source

Decoding the genetic blueprints of neurological disorders: disease mechanisms and breakthrough gene therapies. [PDF]

Front Neurol
Saeed U, Piracha ZZ, Tariq MN, Syed S, Rauf M, Razaq L, Iftikhar MK, Maqsood A, Ahsan SM.   +8 more
europepmc   +1 more source

Time- and spatially resolved LNA delivery via thermally controlled SPION technology. [PDF]

Mol Ther Nucleic Acids
Kenneweg F, Hempel K, Höhne LPJ, Dräger G, Blume J, Viereck T, Stohwasser A, Groß S, Büchler G, Jansen K, Juchem M, Bär C, Pfanne A, Just A, Thum S, Gietz A, Kirschning A, Thum T.   +17 more
europepmc   +1 more source

The role of exosomes as oligonucleotide delivery system for managing α-synuclein in Parkinson's disease: A systematic review of <i>in vivo</i> studies. [PDF]

Mol Ther Nucleic Acids
Salarpour S, Dourandish F, Salajegheh A, Hashemi S.   +3 more
europepmc   +1 more source

Recent advances of metal-organic frameworks (MOFs) for drug delivery, cancer imaging and theranostics. [PDF]

Theranostics
Yu H, Lin G, Mi P.
europepmc   +1 more source

MASQ: A multiplex qPCR platform for quantitative alternative splicing analysis in clinical specimens. [PDF]

Mol Ther Nucleic Acids
Jeong H, Cho N, Park JI, Yoo HJ, Kim KK.
europepmc   +1 more source

RNA-based discovery and correction of splicing defects caused by <i>POLR3A</i> missense mutations. [PDF]

Mol Ther Nucleic Acids
Shkreta L, Delannoy A, Toutant J, McSwiggen J, Chabot B.   +4 more
europepmc   +1 more source